The reported statements, read against the company's own industry.
Financials view
Market Capitalization
315.99BINR
3.37B · vs all stocks (USD)
Updated Oct 29, 2026
Trailing P/E
85.42x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Revenue (TTM)
22.50BINR
240.20M · vs all stocks (USD)
Updated Oct 29, 2026
Profit Margin
16.07%
vs Diagnostics & Research peers
Updated Oct 29, 2026
52-Week Change
62.19%
vs all stocks
Updated Oct 29, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 29, 2026
Market Capitalization
315.99BINR
3.37B · vs all stocks (USD)
Updated Oct 29, 2026
Enterprise Value
316.09BINR
3.37B · vs all stocks (USD)
Updated Oct 29, 2026
Trailing P/E
85.42x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Forward P/E
59.17x
vs Diagnostics & Research peers
Updated Oct 29, 2026
PEG Ratio
-4.64x
Updated Oct 29, 2026
Price to Sales (TTM)
14.04x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Price to Book (MRQ)
12.66x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Enterprise to Revenue
14.05x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Enterprise to EBITDA
47.21x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Gross Margin
41.40%
vs Diagnostics & Research peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 74.46%.Updated Oct 29, 2026
Profit Margin
16.07%
vs Diagnostics & Research peers
Updated Oct 29, 2026
Operating Margin
18.41%
vs Diagnostics & Research peers
Updated Oct 29, 2026
Return on Assets (TTM)
9.62%
vs Diagnostics & Research peers
Updated Oct 29, 2026
Return on Equity (TTM)
14.05%
vs Diagnostics & Research peers
Updated Oct 29, 2026
Revenue (TTM)
22.50BINR
240.20M · vs all stocks (USD)
Updated Oct 29, 2026
Revenue per Share (TTM)
106.83INRUpdated Oct 29, 2026
Quarterly Revenue Growth
11.70%
vs Diagnostics & Research peers
Updated Oct 29, 2026
Gross Profit (TTM)
16.76BINR
178.86M · vs all stocks (USD)
Updated Oct 29, 2026
EBITDA (TTM)
6.71BINR
71.59M · vs all stocks (USD)
Updated Oct 29, 2026
Net Income (TTM)
3.62BINR
38.61M · vs all stocks (USD)
Updated Oct 29, 2026
Quarterly Earnings Growth (YoY)
21.20%
vs Diagnostics & Research peers
Updated Oct 29, 2026
Operating Cash Flow (TTM)
5.09BINR
54.34M · vs all stocks (USD)
Updated Oct 29, 2026
Levered Free Cash Flow (TTM)
3.49BINR
37.24M · vs all stocks (USD)
Updated Oct 29, 2026
Forward Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 29, 2026
Trailing Annual Dividend Rate
0.00INRUpdated Oct 29, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Oct 29, 2026
Payout Ratio
0.00%
vs Diagnostics & Research peers
Updated Oct 29, 2026
Revenue
21.37BINRFY2026 · Mar 31, 2026
Cost of Goods Sold
12.94BINRFY2026 · Mar 31, 2026
Gross Profit
8.42BINRFY2026 · Mar 31, 2026
Operating Income
4.67BINR
49.88M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
4.66BINRFY2026 · Mar 31, 2026
Income Tax Expense
1.17BINRFY2026 · Mar 31, 2026
Net Income
3.49BINRFY2026 · Mar 31, 2026
EBIT
5.05BINRFY2026 · Mar 31, 2026
EBITDA (Income Statement)
6.81BINRFY2026 · Mar 31, 2026
Selling, General & Administrative
774.93MINRFY2026 · Mar 31, 2026
Other Operating Expenses
1.62BINRFY2026 · Mar 31, 2026
Non-operating Interest Income
186.18MINRFY2026 · Mar 31, 2026
Non-operating Interest Expense
392.39MINRFY2026 · Mar 31, 2026
EPS (Basic)
16.63INRFY2026 · Mar 31, 2026
EPS (Diluted)
16.43INRFY2026 · Mar 31, 2026
Basic Shares Outstanding
209.82MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
209.82MSharesFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026
Operating Cash Flow
3.82BINRFY2026 · Mar 31, 2026
Free Cash Flow
-2.10BINRFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
819.14MINRFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
4.66BINRFY2026 · Mar 31, 2026
Stock-based Compensation
21.04MINRFY2026 · Mar 31, 2026
Other Non-cash Items
206.21MINRFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
-154.17MINRFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
-910.87MINRFY2026 · Mar 31, 2026
Capital Expenditures
-5.92BINRFY2026 · Mar 31, 2026
Net Acquisitions
-15.67MINRFY2026 · Mar 31, 2026
Purchase of Investments
-1.16BINRFY2026 · Mar 31, 2026
Sale of Investments
2.92BINRFY2026 · Mar 31, 2026
Net Investing Cash Flow
-4.18BINRFY2026 · Mar 31, 2026
Long-term Debt Issuance
255.04MINRFY2026 · Mar 31, 2026
Long-term Debt Payments
0.00INRFY2026 · Mar 31, 2026
Net Short-term Debt Issuance
-588.90MINRFY2026 · Mar 31, 2026
Net Financing Cash Flow
-82.92MINRFY2026 · Mar 31, 2026
Shares Outstanding
212.47MSharesUpdated Oct 29, 2026
Float Shares
133.29MSharesUpdated Oct 29, 2026
% Held by Insiders
36.28%
vs all stocks
Updated Oct 29, 2026
% Held by Institutions
43.57%
vs all stocks
Updated Oct 29, 2026
Total Cash (MRQ)
1.58BINR
16.85M · vs all stocks (USD)
Updated Oct 29, 2026
Total Cash per Share (MRQ)
7.45INRUpdated Oct 29, 2026
Total Debt (MRQ)
2.88BINR
30.79M · vs all stocks (USD)
Updated Oct 29, 2026
Total Debt to Equity (MRQ)
0.1161x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Current Ratio (MRQ)
1.69x
vs Diagnostics & Research peers
Updated Oct 29, 2026
Book Value per Share (MRQ)
117.47INRUpdated Oct 29, 2026
Total Assets
36.26BINR
387.05M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
14.11BINRFY2026 · Mar 31, 2026
Total Liabilities
11.42BINRFY2026 · Mar 31, 2026
Total Non-current Assets
22.16BINRFY2026 · Mar 31, 2026
Total Non-current Liabilities
3.09BINRFY2026 · Mar 31, 2026
Total Current Liabilities
8.34BINRFY2026 · Mar 31, 2026
Cash & Cash Equivalents
819.14MINRFY2026 · Mar 31, 2026
Other Short-term Investments
1.80BINRFY2026 · Mar 31, 2026
Accounts Receivable
3.74BINRFY2026 · Mar 31, 2026
Inventory
1.51BINRFY2026 · Mar 31, 2026
Accounts Payable
2.85BINRFY2026 · Mar 31, 2026
Short-term Debt
1.40BINRFY2026 · Mar 31, 2026
Other Current Liabilities
1.73BINRFY2026 · Mar 31, 2026
Long-term Debt
1.48BINRFY2026 · Mar 31, 2026
Common Stock (Book)
211.78MINRFY2026 · Mar 31, 2026
Total Shareholders' Equity
24.84BINR
265.11M · vs all stocks (USD)
FY2026 · Mar 31, 2026
52-Week Low
783.85INRUpdated Oct 29, 2026
52-Week High
1.70KINRUpdated Oct 29, 2026
52-Week Change
62.19%
vs all stocks
Updated Oct 29, 2026
50-Day MA
1.51KINRUpdated Oct 29, 2026
200-Day MA
1.20KINRUpdated Oct 29, 2026
Avg 10-Day Volume
412.72KSharesUpdated Oct 29, 2026
Avg 30-Day Volume
447.60KSharesUpdated Oct 29, 2026
Diluted EPS (TTM)
17.41INRUpdated Oct 29, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Is this company growing?
Multi-Year Revenue And Profit Growth
Revenue and earnings have both grown steadily across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.